Chemokine Therapeutics Corp., of Vancouver, British Columbia, appointed Shahin Rafii to its scientific and clinical advisory boards

Xillix Technologies Corp., of Richmond, British Columbia, appointed Rob Ngungu vice president, quality, clinical and regulatory affairs

iCo Therapeutics Inc., of Vancouver, British Columbia, appointed Santa Jeremy Ono chief scientific officer...Intrac Inc., of New York, and its subsidiary Innovative Drug Delivery Systems, appointed William Peters to its board

Dragon Pharmaceutical Inc., of Vancouver, British Columbia, appointed Xiaochun Zhang general manager of Chinese operations...Imagenetix Inc., of San Diego, appointed Jason Theodosakis and Lorna Vanderhaeghe to its scientific and medical advisory board

MIV Therapeutics Inc., of Vancouver, British Columbia, appointed Dean-Mo Liu chief scientist, drug delivery technologies...Neurorecovery Inc., of Tuscaloosa, Ala., appointed Ben Labry and James Terwilliger to oversee business development and marketing activities

Alda Pharmaceuticals Corp., of Vancouver, British Columbia, appointed William McCoy to its board...Biocom, of San Diego, appointed Jack Lief chairman and added new board members Dana Di Ferdinando, Larry Fitch, Mary Lyons, Randall Woods and Kleanthis Xanthopoulos

Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Gary Ingenito senior vice president, clinical development and regulatory affairs

Cardiome Pharma Corp., of Vancouver, British Columbia, appointed Charles Fisher chief medical officer and executive vice president of clinical and regulatory affairs

plc, of London, appointed Simon Kukes and Michael Walsh nonexecutive directors...AnorMed Inc., of Vancouver, British Columbia, appointed Eve Slater to its board

Members are Timothy Henry, Robert Simari and Byron Williams...Inex Pharmaceuticals Corp., of Vancouver, British Columbia, appointed Timothy Ruane senior vice president, corporate development

Forbes Medi-Tech Inc., of Vancouver, British Columbia, appointed Steven Nissen chairman of its medical and scientific advisory board...Response Biomedical Corp., of Vancouver, British Columbia, appointed Sidney Braginsky to its board, and Robert Pilz chief financial officer and vice president of finance

enGene Inc., of Vancouver, British Columbia, appointed Hector MacKay-Dunn and Jack Wood to its board

and Michael Keavany senior vice president of sales and marketing...Response Biomedical Corp., of Vancouver, British Columbia, appointed Michael Groves vice president of sales and marketing

Cardiome Pharma Corp., of Vancouver, British Columbia, appointed Harold Shlevin and Jackie Clegg independent directors

Neurome Inc., of La Jolla, Calif., appointed Michael Khoury and Joseph Wender to its board...Neuromed Technologies Inc., of Vancouver, British Columbia, appointed Mark Corrigan to its board

Nuvios Inc., of Cambridge, Mass., appointed Richard Lyttle president and CEO...OncoGenex Technologies Inc., of Vancouver, British Columbia, appointed Neil Clendeninn to its board

and Jinsam You, Tony Tegeler and Dariusz Janecki to its scientific team...and Howard Simon senior vice president of human resources and associated general counsel

Chromos Molecular Systems Inc., of Burnaby, British Columbia, appointed Phillip Maples vice president of clinical development and manufacturing, Alan Hardwick vice president of process development and Kathryn Hayashi vice president of finance

DuPont, of Wilmington, Del., appointed Kevin Fitzgerald and Sven Thormahlen to its biotechnology advisory panel...ID Biomedical, of Vancouver, British Columbia, appointed John Trizzino senior vice president of business development